belimumabtelitaciceptSLEsystemic lupus erythematosus
…Objectives Both telitacicept and belimumab are approved for treating active systemic lupus erythematosus (…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…Objectives Both telitacicept and belimumab are approved for treating active systemic lupus erythematosus (…
…Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for t…
…oral small molecule kinase inhibitors, such as upadacitinib and deucravacitinib, as potential additions to standard of care in SLE, considering…